Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
| Autor: | Jiang, Zefei, Li, Wei, Hu, Xichun, Zhang, Qingyuan, Sun, Tao, Cui, Shude, Wang, Shusen, Ouyang, Quchang, Yin, Yongmei, Geng, Cuizhi, Tong, Zhongsheng, Cheng, Ying, Pan, Yueyin, Sun, Yuping, Wang, Hong, Ouyang, Tao, Gu, Kangsheng, Feng, Jifeng, Wang, Xiaojia, Wang, Shubin, Liu, Tianshu, Gao, Jinghua, Cristofanilli, Massimo, Ning, Zhiqiang, Lu, Xianping |
|---|---|
| Zdroj: | In The Lancet Oncology June 2019 20(6):806-815 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|